Renal Abscess

1. Clinical Overview

Summary

A renal abscess is a focal collection of purulent material within or around the kidney parenchyma, representing a severe and potentially life-threatening complication of upper urinary tract infection. Renal abscesses encompass a spectrum of disease from intrarenal cortical abscesses (also known as renal carbuncles) to corticomedullary abscesses and perinephric (perirenal) abscesses that extend beyond the renal capsule into the perinephric fat. [1,2]

The epidemiology and microbiology of renal abscesses have evolved significantly over the past several decades. Historically, renal cortical abscesses predominantly resulted from haematogenous seeding by Staphylococcus aureus from distant foci such as skin infections or endocarditis. However, contemporary series demonstrate that ascending infection from the lower urinary tract with Gram-negative organisms (particularly Escherichia coli) now accounts for 75-90% of cases, reflecting improved management of bacteraemia and changing patterns of antimicrobial resistance. [3,4]

The pathophysiology differs fundamentally between haematogenous and ascending infections. Haematogenous spread typically seeds the highly vascular renal cortex, creating solitary abscesses with staphylococcal aetiology. In contrast, ascending infections occur in the setting of urinary stasis (from obstruction due to calculi, anatomical abnormalities, or vesicoureteral reflux) and progress from acute pyelonephritis to liquefactive necrosis with polymicrobial Gram-negative flora. Extension beyond Gerota's fascia indicates perinephric involvement and carries significantly worse prognosis. [5,6]

Diabetes mellitus is the single most important risk factor, present in 40-70% of patients with renal abscess. Diabetic patients exhibit multiple predisposing factors including impaired neutrophil function, altered urinary pH favouring bacterial growth, increased glycosuria, autonomic neuropathy causing incomplete bladder emptying, and increased susceptibility to papillary necrosis. [7,8]

Clinical presentation is often insidious and non-specific, with fever, flank pain, and malaise developing over days to weeks. Unlike uncomplicated pyelonephritis, symptoms persist or worsen despite appropriate antimicrobial therapy. Physical examination may reveal costovertebral angle tenderness, palpable flank mass, or signs of psoas irritation (suggesting perinephric extension). Laboratory studies show leucocytosis and elevated inflammatory markers, but urinalysis may be normal in up to 30% of cases, particularly in walled-off abscesses or haematogenous infection. [9,10]

Contrast-enhanced computed tomography (CT) is the gold standard diagnostic modality, demonstrating characteristic rim-enhancing hypodense lesions with central liquefaction. CT provides superior anatomical delineation, identifies complications (gas formation, perinephric extension, obstruction), and guides interventional procedures. Ultrasound has limited sensitivity for early or small abscesses but may be useful for drainage guidance. [11,12]

Management requires a dual approach of antimicrobial therapy and source control through drainage when appropriate. Empirical antibiotics must provide broad-spectrum Gram-negative coverage (with anti-pseudomonal activity in healthcare-associated infection or instrumentation) and consideration of anti-staphylococcal therapy in suspected haematogenous spread or confirmed methicillin-resistant S. aureus (MRSA). Percutaneous drainage under image guidance represents the primary interventional approach for abscesses > 3-5cm or those failing conservative management, with surgical drainage reserved for complex collections, multiloculated abscesses, or coexisting pathology requiring operative intervention. [13,14]

Contemporary data indicate mortality of 2-12% overall, rising to 20-40% in emphysematous pyelonephritis or perinephric abscess with delayed diagnosis. Outcomes depend critically on timely diagnosis, appropriate source control, management of underlying risk factors (particularly glycaemic control in diabetics), and relief of any obstructive uropathy. [15,16]

Clinical Pearls

"Pyelonephritis That Doesn't Improve": The cardinal diagnostic clue is persistent fever beyond 48-72 hours of appropriate antibiotics. Any patient with presumed pyelonephritis who remains febrile or deteriorates on therapy requires urgent cross-sectional imaging to exclude abscess formation.

"Diabetics Are High Risk": Diabetes mellitus is present in 40-70% of renal abscess cases. Multiple mechanisms contribute: impaired neutrophil function, incomplete bladder emptying from autonomic neuropathy, papillary necrosis, and hyperglycaemia creating favourable environment for bacterial proliferation. Aggressive glycaemic control is essential adjunctive therapy.

"Ascending Has Overtaken Haematogenous": Modern series show 75-90% are ascending Gram-negative infections (predominantly E. coli), compared to historical predominance of haematogenous S. aureus. However, IVDU, endocarditis, or distant staphylococcal infection should prompt consideration of haematogenous aetiology even in contemporary practice.

"CT Trumps Ultrasound": Contrast-enhanced CT has sensitivity > 90% for renal abscess, while ultrasound sensitivity is only 60-85% and frequently misses early or small abscesses. USS may show a non-specific complex cystic lesion; CT is mandatory for definitive diagnosis and surgical planning.

"Size Matters for Drainage": While no absolute threshold exists, abscesses > 5cm almost always require drainage given failure rates > 50% with antibiotics alone. The 3-5cm range is debated; clinical response, patient comorbidities, and anatomical complexity guide decision-making. Multiloculated collections or those with thick walls favour intervention.

"Psoas Sign = Perinephric Extension": Pain on hip extension or flexion deformity indicates psoas muscle irritation from perinephric abscess extending anteriorly. This finding substantially worsens prognosis and may necessitate surgical rather than percutaneous drainage.

"Gas = Emphysematous Pyelonephritis = Emergency": Detection of gas within the abscess or renal parenchyma on CT indicates emphysematous pyelonephritis, a necrotising gas-forming infection almost exclusively in diabetics. This constitutes a urological emergency with mortality 20-40% requiring aggressive resuscitation, broad-spectrum antibiotics, urgent drainage, and potential emergency nephrectomy.

"Sterile Pyuria Suggests Walled-Off Abscess": Urine cultures may be negative in 30% of renal abscesses due to complete walling-off or haematogenous seeding. Blood cultures are positive in 30-50%. Always pursue imaging in clinically suspected cases regardless of urinalysis findings.

---

2. Epidemiology

Demographics

Risk Factors

Exam Detail: MRCP/Viva Examination Point: Be prepared to discuss why diabetes is such a dominant risk factor with mechanistic detail:

1. Neutrophil Dysfunction: Hyperglycaemia impairs neutrophil chemotaxis, adherence, and phagocytic capacity through advanced glycation end-products affecting cellular machinery
2. Favourable Bacterial Environment: Glycosuria provides substrate for bacterial metabolism; altered urinary pH; increased iron availability
3. Neuropathy: Autonomic dysfunction causes incomplete bladder emptying and loss of normal voiding reflexes, promoting urinary stasis
4. Vascular Disease: Microangiopathy reduces renal perfusion and antibiotic delivery; impairs local immune response
5. Papillary Necrosis: Diabetic papillary necrosis creates devitalised tissue that resists antibiotic penetration and provides nidus for abscess formation
6. Delayed Diagnosis: Diabetic neuropathy may blunt symptom perception, leading to later presentation

The cumulative effect of these factors explains why diabetics have 10-20 fold increased risk of abscess formation when pyelonephritis occurs, and why aggressive glycaemic control is mandatory adjunctive therapy.

---

3. Aetiology and Pathophysiology

Routes of Infection

Pathophysiology: Ascending Infection

Stage 1: Acute Pyelonephritis

• Bacteria ascend from lower urinary tract via ureters
• Predisposing factors: obstruction (stasis), reflux, instrumentation
• Organisms adhere to uroepithelium via fimbriae (P fimbriae for E. coli)
• Invasion of renal pelvis and collecting ducts
• Acute tubular and interstitial inflammation
• If treated promptly: resolution without abscess formation

Stage 2: Liquefactive Necrosis

• Inadequate antibiotic therapy OR delayed presentation OR overwhelming bacterial load
• Bacterial toxins (endotoxin, haemolysin, exotoxins) cause tissue necrosis
• Neutrophil infiltration and death releases proteolytic enzymes
• Liquefactive necrosis creates purulent collection
• Initially at corticomedullary junction (zone of maximal bacterial concentration)
• Abscess typically 2-5cm; may be solitary or multiple

Stage 3: Abscess Maturation

• Fibrous capsule forms around liquefied centre (takes 7-14 days)
• Capsule limits antibiotic penetration (avascular scar tissue)
• Abscess may rupture through renal capsule → perinephric abscess
• Alternatively, may decompress into collecting system → pyuria, bacteriuria

Complications of Ascending Infection:

• Perinephric extension: Rupture beyond capsule into perirenal fat (within Gerota's fascia)
• Paranephric extension: Beyond Gerota's into retroperitoneum (rare, very severe)
• Psoas abscess: Direct extension into psoas muscle
• Fistula formation: To bowel (especially with E. coli, inflammatory bowel disease)
• Emphysematous change: Gas-forming organisms (E. coli, Klebsiella, Clostridium)

[6,9,10]

Pathophysiology: Haematogenous Infection

Stage 1: Bacteraemia

• Distant focus: skin abscess, cellulitis, endocarditis, osteomyelitis, catheter-related infection
• Transient or persistent bacteraemia with S. aureus (occasionally Streptococcus)
• In IVDU: direct introduction of bacteria; particulate matter causing septic emboli

Stage 2: Cortical Seeding

• Renal cortex has 20% of cardiac output → high bacterial exposure
• Bacteria lodge in glomerular capillaries or afferent arterioles
• Focal area of ischaemia and microabscess formation
• Coalescing microabscesses form larger cortical abscess ("renal carbuncle")
• Typically solitary, located in cortex, well-demarcated

Stage 3: Local Spread

• Cortical abscess may extend medially toward medulla
• Less commonly ruptures through capsule (as cortical location is peripheral)
• May track along perinephric fat
• Occasionally spontaneous resolution with antibiotic therapy if caught early

Distinguishing Features of Haematogenous Abscess:

• No prior UTI history in 70% of cases
• Urine cultures often sterile (25-40% of cases) as infection bypasses urinary tract
• Blood cultures more likely positive (50-70%) than in ascending type
• Single organism (usually S. aureus) rather than polymicrobial
• Younger, healthier patients (except IVDU) compared to ascending type
• Cortical location on imaging (characteristic of carbuncle)

[5,13,19]

Exam Detail: ### Molecular Mechanisms: Why E. coli Dominates Ascending Infection

Virulence Factors of Uropathogenic E. coli (UPEC):

1. P Fimbriae (Pyelonephritis-associated pili): Adhesins binding to P blood group antigens on uroepithelium; mediate ascent to upper tract; associated with 90% of pyelonephritis strains
2. Type 1 Fimbriae: Mannose-binding adhesins; facilitate bladder colonisation; phase variation allows switching between adherent and motile phenotypes
3. Haemolysin: Pore-forming toxin; lyses erythrocytes, neutrophils, renal tubular cells; releases iron for bacterial metabolism; present in 50% of pyelonephritis E. coli
4. Aerobactin: Siderophore for iron acquisition in iron-limited environment of urine/tissue
5. Capsular Polysaccharide (K antigen): Inhibits complement activation and phagocytosis; K1 capsule especially associated with invasive disease
6. Flagella (H antigen): Motility enabling ascent against urine flow; chemotaxis toward chemical gradients

Progression from Pyelonephritis to Abscess:

• Requires obstruction (creates closed space with elevated pressure and stasis) OR
• Immunosuppression (allows unchecked bacterial proliferation) OR
• Delayed/inadequate antibiotic therapy (sub-therapeutic levels in tissue) OR
• Biofilm formation on foreign material (catheters, stents) conferring 1000-fold antibiotic resistance

The shift from acute inflammation to liquefactive necrosis involves balance between bacterial virulence and host response. Abscess formation represents a "failure" of the immune system to eradicate infection, creating walled-off pus collection that paradoxically protects bacteria from both immune cells and antibiotics.

Classification of Renal Abscesses

[2,5,11]

---

4. Clinical Presentation

Symptoms

Temporal Pattern

Acute Presentation (20-30% of cases):

• Rapid onset over 24-72 hours
• High fever, rigors, severe flank pain
• Often following recent instrumentation or in immunocompromised
• May progress to septic shock
• Mimics acute pyelonephritis until imaging performed

Subacute/Insidious Presentation (70-80% of cases):

• Gradual onset over days to weeks
• Low-grade fever, intermittent
• Vague flank discomfort
• Progressive malaise and weight loss
• Classical error: Misdiagnosis as viral illness, recurrent UTI, or missed diagnosis for weeks
• Average diagnostic delay: 7-14 days from symptom onset [9]

[9,10,20]

Physical Examination Findings

Exam Detail: ### Examination Technique: Eliciting Psoas Sign

Method:

1. Patient supine, fully relaxed
2. Examiner places hand under patient's lumbar spine (to stabilise)
3. Passively extend patient's hip by lifting thigh upward and backward
4. Positive test: Pain in flank/lower abdomen on affected side

Anatomical Basis:

• Psoas major muscle lies anterior to kidneys, within psoas fascia
• Kidney enclosed in Gerota's fascia, posterior to psoas
• Perinephric abscess may extend anteriorly to contact/invade psoas muscle or fascia
• Hip extension stretches psoas muscle → irritates adjacent abscess → pain

Clinical Significance:

• Psoas sign has specificity 70-80% for perinephric extension (when combined with clinical context)
• Also positive in psoas abscess (may be secondary to renal abscess tracking along muscle)
• May be positive in appendicitis (especially retrocaecal), diverticulitis, pelvic abscess
• Negative psoas sign does NOT exclude perinephric abscess (sensitivity only 30-50%)

Prognostic Implication:

• Presence of psoas sign suggests perinephric abscess (not simple intrarenal)
• Perinephric abscess has 2-3 fold higher mortality than intrarenal
• More likely to require surgical (not percutaneous) drainage
• Longer antibiotic courses required (4-6 weeks vs 2-4 weeks)

---

5. Differential Diagnosis

[9,11,12]

---

6. Investigations

Laboratory Investigations

Imaging

Contrast-Enhanced CT (Gold Standard)

Indications:

• Any patient with pyelonephritis not improving within 48-72h of antibiotics [11,12]
• Suspected renal abscess on clinical grounds (persistent fever, flank mass, high-risk patient)
• Immunocompromised with UTI
• Diabetes with pyelonephritis and high inflammatory markers
• Recurrent pyelonephritis in same location
• Pyelonephritis with urinary obstruction

Protocol:

• Non-contrast phase: Identify calculi, baseline attenuation, haemorrhage
• Arterial phase (25-30s post-contrast): Assess vascularity, exclude renal artery stenosis
• Nephrographic phase (80-100s): Optimal for abscess detection - shows rim enhancement
• Excretory phase (5-10 min): Assess collecting system, obstruction, communication with abscess

CT Findings in Renal Abscess: [11,12]

Sensitivity/Specificity: CT has sensitivity 90-95%, specificity 85-90% for renal abscess [11]

Ultrasound (USS)

Role:

• NOT first-line for diagnosis (sensitivity only 60-85%, misses early/small abscesses)
• Useful in pregnancy (avoid radiation)
• Guidance for percutaneous drainage
• Screening in children or young adults (radiation concern)
• Follow-up after drainage (assess resolution)

USS Findings:

• Hypoechoic or anechoic collection (fluid)
• Thick irregular wall
• Internal echoes/debris (pus)
• Increased vascularity on Doppler (rim vascularity)
• May be indistinguishable from complex cyst, haematoma, or tumour

Limitations:

• Operator-dependent
• Bowel gas interference
• Obesity limits visualisation
• Cannot assess degree of perinephric extension or obstruction as well as CT

Recommendation: If USS suggests abscess or complex cystic lesion in appropriate clinical context, proceed to CT for definitive diagnosis and planning. [12]

MRI

Indications:

• Pregnancy (if USS non-diagnostic)
• Renal impairment (CT contrast contraindicated)
• Allergy to iodinated contrast
• Differentiate abscess from tumour (diffusion-weighted imaging)

MRI Findings:

• T1: Hypointense centre (pus = fluid signal)
• T2: Hyperintense centre
• Post-gadolinium: Rim enhancement (similar to CT)
• DWI: Restricted diffusion (pus has high cellularity)

Advantages: No radiation; excellent soft tissue contrast; DWI helps differentiate abscess (restricted diffusion) from sterile collection or tumour necrosis Disadvantages: Expensive; less available; longer acquisition time; inferior for calculi detection

Plain Radiography (KUB)

Limited role:

• May show loss of psoas shadow (non-specific, indicates retroperitoneal process)
• Radiopaque calculi (but USS/CT superior)
• Gas in renal outline (emphysematous pyelonephritis) - but CT mandatory for confirmation
• Scoliosis (curvature toward affected side)

Conclusion: Plain X-ray cannot diagnose abscess and should NOT delay CT if abscess suspected.

[11,12,20]

Percutaneous Aspiration

Indications:

• Confirm diagnosis if imaging equivocal (differentiate abscess from tumour, cyst)
• Obtain cultures for organism identification and sensitivities (especially if blood/urine cultures negative)
• Therapeutic: Small abscesses (2-4cm) may be treated with single aspiration + antibiotics

Procedure:

• USS or CT guidance
• Send fluid for: Gram stain, bacterial culture (aerobic/anaerobic), TB culture (if chronic/sterile), fungal culture (immunosuppressed)
• Fluid appearance: Purulent, turbid; confirm pus (not sterile fluid, haematoma, or tumour necrosis)

Culture Yield: Abscess fluid culture positive in 80-90% (higher than blood/urine cultures)

---

7. Management

Initial Resuscitation and Assessment

Step 1: Recognise and Stabilise Sepsis [14,15]

If sepsis or septic shock present (qSOFA ≥2, lactate > 2 mmol/L, hypotension):

1. IV access and bloods (FBC, U&E, CRP, lactate, blood cultures × 2, glucose)
2. Fluid resuscitation: 30 mL/kg crystalloid in first 3 hours
3. Empirical antibiotics within 1 hour (see below)
4. Oxygen to maintain SpO₂ > 94%
5. Urinary catheter and monitor urine output (target > 0.5 mL/kg/h)
6. Lactate monitoring: Repeat at 2-4h to assess response
7. Vasopressors (noradrenaline) if hypotension persists despite fluids (MAP target > 65 mmHg)
8. HDU/ICU if shock, lactate > 4, or organ support required

Step 2: Imaging [11,12]

• Contrast-enhanced CT abdomen/pelvis as soon as haemodynamically stable (within 12-24h of presentation)
• Identify: size, location, number of abscesses; gas; perinephric extension; hydronephrosis/obstruction

Step 3: Source Control Decision [13,14]

Based on CT findings, decide:

• Antibiotics alone vs
• Percutaneous drainage vs
• Surgical drainage

---

Management Algorithm

SUSPECTED RENAL ABSCESS
(Persistent fever in pyelonephritis, high-risk patient, clinical suspicion)
                    ↓
INVESTIGATIONS
- Bloods: FBC, CRP, U&E, lactate, blood cultures × 2, HbA1c
- Urine: Dipstick, MC&S (before antibiotics if possible)
- Imaging: **CT Abdomen/Pelvis with IV Contrast** (GOLD STANDARD)
                    ↓
CONFIRM ABSCESS ON CT
Assess:
- Size (largest diameter)
- Location (intrarenal vs perinephric)
- Number (solitary vs multiple)
- Complications (gas, hydronephrosis, perinephric extension)
                    ↓
INITIAL MANAGEMENT (ALL PATIENTS)
1. **IV Broad-Spectrum Antibiotics** (see regimens below)
2. **IV Fluids** and supportive care
3. **Analgesia** (paracetamol, NSAIDs if not AKI, opioids if severe)
4. **Optimise glycaemic control** if diabetic (insulin sliding scale if HbA1c > 8%)
5. **Monitor**: Temperature, inflammatory markers (CRP/PCT), renal function
                    ↓
ASSESS FOR DRAINAGE
    ┌──────────────────────┴──────────────────────┐
SMALL ABSCESS                               LARGE ABSCESS
(less than 3cm, selected less than 5cm)                       (> 5cm)
No complications                            OR
Immunocompetent                             OR
Responding clinically                       OR
    ↓                                       OR
**CONSERVATIVE**                                 ↓
- IV antibiotics 7-14 days                  **DRAINAGE INDICATED**
- Switch to PO when afebrile > 48h           - Failure to respond to Abx (48-72h persistent fever)
- Total duration 2-4 weeks                  - Multiloculated abscess
- Repeat imaging at 1-2 weeks               - Gas-forming infection
  to confirm resolution                     - Immunocompromised host
- Clinical review: if fever                 - Perinephric abscess
  persists > 72h, proceed to                 - Abscess size increasing on imaging
  drainage                                       ↓
                                            **PERCUTANEOUS DRAINAGE** (First-line)
                                            - CT/USS-guided catheter insertion
                                            - 8-12F pigtail catheter
                                            - Send fluid: Gram stain, culture (aerobic/anaerobic/TB/fungal)
                                            - Leave catheter until drainage less than 10 mL/24h
                                            - Success rate: 70-90%
                                                 ↓
                                            Monitor response:
                                            - Fever should resolve within 48-72h
                                            - CRP/PCT trend downward
                                            - Drain output decreases
                                                 ↓
                                            If percutaneous drainage FAILS:
                                            - Persistent fever > 72h post-drainage
                                            - Inadequate drainage (multiloculated)
                                            - Anatomical constraints
                                                 ↓
                                            **SURGICAL DRAINAGE**
                                            - Open or laparoscopic
                                            - Debride and drain abscess
                                            - Remove necrotic tissue
                                            - Nephrectomy if non-functioning kidney + life-threatening sepsis
                    ↓
RELIEVE OBSTRUCTION (If Present)
- Ureteric stent OR
- Percutaneous nephrostomy
- Definitive stone treatment (delayed, after infection controlled)
                    ↓
ANTIBIOTIC DURATION
- IV: Until afebrile > 48-72h AND improving clinically (typically 7-14 days)
- PO: Continue to total duration 2-4 weeks (intrarenal) or 4-6 weeks (perinephric)
- Adjust based on culture sensitivities
- Monitor CRP/PCT to guide duration
                    ↓
FOLLOW-UP
- Repeat CT at 2-4 weeks to confirm resolution
- Investigate underlying cause (DM control, urological assessment if obstruction/stones)
- Functional imaging (MAG3, DMSA) if concern for renal damage

[13,14,15]

---

Antibiotic Therapy

Empirical Regimens (Before Culture Results)

Choice depends on:

1. Route of infection (ascending vs haematogenous)
2. Healthcare-associated risk factors (recent hospitalisation, catheter, ESBL risk)
3. Local resistance patterns
4. Severity of illness (sepsis, organ dysfunction)

Dosing Adjustments:

• Renal impairment: Dose-reduce according to CrCl (especially aminoglycosides, vancomycin, carbapenems)
• Obesity: Consider weight-based dosing for aminoglycosides, vancomycin, daptomycin
• Elderly: Increased risk of nephrotoxicity; monitor renal function closely

[13,14,19]

Targeted Therapy (Once Culture Results Available)

Switch from empirical to targeted therapy based on culture sensitivities (blood, urine, or abscess fluid):

Route Transition:

• IV → PO switch when: Afebrile > 48-72h, haemodynamically stable, CRP/PCT declining, tolerating oral, GI absorption intact
• Oral options (based on sensitivities): Ciprofloxacin 500-750mg BD, Co-amoxiclav 625mg TDS, Cefalexin 500mg QDS, Trimethoprim 200mg BD

Total Antibiotic Duration:

• Intrarenal abscess: 2-4 weeks total (IV 7-14 days + PO to complete)
• Perinephric abscess: 4-6 weeks total (IV 10-21 days + PO to complete)
• Drained abscess: May shorten to 2-3 weeks if good source control and clinical response
• Undrained small abscess: Minimum 4 weeks
• Immunocompromised: Add 1-2 weeks to standard duration

Monitoring:

• Daily: Temperature, inflammatory markers trend
• Every 2-3 days: FBC, CRP, renal function
• Weekly: Procalcitonin (if initially elevated, to guide duration)
• Target: Afebrile, CRP less than 50 mg/L, clinical improvement before stopping IV antibiotics
• Repeat imaging: At 1-2 weeks to assess abscess size reduction

[13,14,15,19]

---

Percutaneous Drainage

Indications: [13,14]

• Abscess > 5cm (strong indication; failure rate > 50% with antibiotics alone)
• Abscess 3-5cm with poor clinical response at 48-72h of antibiotics
• Multiloculated abscess
• Gas-forming infection (emphysematous pyelonephritis)
• Immunocompromised host (lower threshold for drainage)
• Perinephric abscess (almost always requires drainage)
• Need for microbiological diagnosis (culture-negative sepsis)

Contraindications:

• Relative: Coagulopathy (correct INR less than 1.5, platelets > 50), single functioning kidney (risk of damage), extensive multiloculation (surgery preferred), anatomical constraints (bowel/lung in path)

Procedure:

• CT or USS guidance
• Prone or lateral position (dependent on abscess location)
• Local anaesthetic ± conscious sedation
• Trocar or Seldinger technique
• 8-12F pigtail catheter insertion into abscess cavity
• Aspirate pus; send for Gram stain, culture (aerobic/anaerobic/TB/fungal)
• Secure catheter and attach to drainage bag
• Post-procedure imaging to confirm position

Post-Drainage Management:

• Monitor drain output (should decrease over 3-7 days)
• Remove drain when: Output less than 10 mL/24h for 2 consecutive days AND clinical improvement (afebrile, improving inflammatory markers) AND repeat imaging shows abscess resolution/significant size reduction
• Typical drainage duration: 5-14 days
• Continue IV antibiotics during drainage

Success Rate: 70-90% for solitary intrarenal abscesses; lower (50-70%) for perinephric or multiloculated

Failure of Percutaneous Drainage (proceed to surgery):

• Persistent fever > 72h post-drainage
• Inadequate drainage (thick pus, debris, multiloculation)
• Drain dislodgement with inability to re-site
• Anatomical contraindications
• Concurrent surgical pathology (stones requiring lithotomy, non-functioning kidney)

[13,14,15]

---

Surgical Drainage

Indications:

• Failed percutaneous drainage
• Multiloculated abscess not amenable to percutaneous approach
• Perinephric abscess with thick fibrous capsule
• Concurrent surgical pathology (large stones, PUJ obstruction, tumour)
• Emphysematous pyelonephritis not responding to percutaneous drainage
• Non-functioning kidney with life-threatening sepsis → Nephrectomy

Approaches:

• Open surgery: Flank incision (lateral or posterior approach); direct visualisation; debride necrotic tissue; drain abscess; leave surgical drains
• Laparoscopic: Selected cases; less invasive; longer operating time; requires expertise
• Nephrectomy: Last resort; indications: non-functioning kidney + refractory sepsis, emphysematous pyelonephritis with extensive necrosis, xanthogranulomatous pyelonephritis

Post-Operative Management:

• Surgical drains remain until output minimal
• Continue IV antibiotics 10-14 days post-op → PO to complete 4-6 weeks total
• Monitor renal function (may have temporary or permanent GFR loss)
• Address underlying cause (stones, obstruction)

[13,14]

---

Relief of Obstruction

Critical Principle: Source control is impossible with persistent obstruction. Antimicrobials cannot reach infected tissue proximal to obstruction, and pus cannot drain. [14,15]

Assess for Obstruction on CT:

• Hydronephrosis (dilated pelvis and calyces)
• Hydroureter (dilated ureter)
• Obstructing stone, stricture, PUJ obstruction, extrinsic compression

If Obstruction Present:

1. Emergency Decompression (within 12-24h):

   • Ureteric stent (retrograde JJ stent via cystoscopy) OR
   • Percutaneous nephrostomy (antegrade drainage via flank puncture)
   • Choice depends on: local expertise, patient anatomy, level of obstruction, presence of pyonephrosis (nephrostomy preferred if purulent urine in collecting system)

2. Definitive Treatment (delayed until infection controlled):

   • Stone: ESWL, URS, PCNL (minimum 4-6 weeks after infection resolved)
   • Stricture: Endoscopic incision, balloon dilatation, or pyeloplasty
   • PUJ obstruction: Anderson-Hynes pyeloplasty

Failure to relieve obstruction results in:

• Treatment failure despite antibiotics and drainage
• Progression to pyonephrosis
• Septic shock
• Permanent renal damage

---

Special Situations

Emphysematous Pyelonephritis

Definition: Necrotising gas-forming infection of renal parenchyma and/or perinephric tissue [15,16]

Organisms: E. coli (70%), Klebsiella pneumoniae (15%), Proteus, Clostridium (rare)

Risk Factors: Diabetes (> 90% of cases), urinary obstruction

CT Findings: Gas within renal parenchyma (Type 1: streaky/mottled gas) or perinephric space (Type 2: bubbly/crescent gas)

Management:

• Aggressive resuscitation (often septic shock)
• Broad-spectrum IV antibiotics (meropenem or pip-tazo)
• Urgent drainage: Percutaneous nephrostomy + abscess drainage
• Emergency nephrectomy if: bilateral involvement (unilateral nephrectomy), refractory septic shock despite maximal therapy, extensive necrosis (> 50% parenchyma)

Mortality: 20-40% despite treatment; nephrectomy reduces mortality to 10-20%

Pregnancy

Considerations:

• Avoid CT (radiation); use USS and MRI (gadolinium only if essential)
• Empirical antibiotics: Ceftriaxone (safe in all trimesters); avoid aminoglycosides (ototoxicity), fluoroquinolones (cartilage damage)
• Percutaneous drainage carries theoretical risk to fetus but usually safe; benefits outweigh risks if large abscess
• Multidisciplinary care (Obstetrics, Urology, Infectious Diseases)

Immunosuppression (HIV, Transplant, Chemotherapy)

Broadened Microbial Differential:

• Bacteria: Usual organisms + Nocardia, Actinomyces
• Fungi: Candida spp., Aspergillus, Cryptococcus, Mucor
• Mycobacteria: M. tuberculosis, non-tuberculous mycobacterials

Investigations: Send abscess fluid for fungal culture, TB culture, AFB stain

Empirical Therapy: Add antifungal coverage (fluconazole 400mg OD or micafungin 100mg OD) to antibacterial regimen if severely immunosuppressed (CD4 less than 100, neutropoenia less than 0.5)

Aggressive Source Control: Lower threshold for drainage (even 2-3cm abscesses)

---

8. Complications

[6,15,16,18,20]

---

9. Prognosis and Outcomes

Mortality

Predictors of Poor Outcome

Clinical:

• Age > 65 years
• Delayed diagnosis (> 7 days from symptom onset to imaging)
• Septic shock at presentation
• Multi-organ dysfunction
• Thrombocytopoenia (less than 100 × 10⁹/L)

Radiological:

• Abscess > 7cm
• Bilateral involvement
• Gas-forming infection
• Perinephric or paranephric extension
• Multiloculated abscess

Microbiological:

• Polymicrobial infection
• MDR organisms (ESBL, MRSA, Pseudomonas)
• Fungal aetiology

Management:

• Failure of percutaneous drainage
• Need for nephrectomy
• Persistent bacteraemia despite source control

[15,16,20]

Renal Functional Outcome

• Unilateral abscess: Usually preserved overall renal function (contralateral kidney compensates), but affected kidney may have 20-50% function loss on split renal function studies (MAG3, DMSA)
• Bilateral or single kidney: Risk of CKD progression (10-30% develop eGFR less than 45 mL/min) [18]
• Emphysematous pyelonephritis: If nephrectomy required, becomes dependent on single kidney; lifelong CKD monitoring
• Follow-up: Repeat creatinine and eGFR at 3, 6, 12 months post-infection

Quality of Life

• Majority of patients return to baseline after treatment
• Chronic pain (5-10%): Related to scarring, perinephric fibrosis
• Recurrent UTI (10-20%): Especially if underlying anatomical abnormality or VUR
• Psychological impact: Prolonged illness, ICU admission, nephrectomy (body image)

---

10. Prevention

Primary Prevention

Secondary Prevention (Prevent Recurrence)

• Address underlying cause: Stones, obstruction, VUR, diabetes, immunosuppression
• Complete antibiotic course: Full duration (2-6 weeks depending on severity); do not stop early even if feeling better
• Follow-up imaging: Confirm complete abscess resolution (repeat CT at 4-6 weeks)
• Remove foreign material: Catheters, stents (biofilm source)
• Antibiotic prophylaxis: Consider low-dose prophylaxis (nitrofurantoin 50mg ON, trimethoprim 100mg ON) in recurrent UTI with structural abnormality

---

11. Key Guidelines and Evidence

Guidelines

Landmark Studies and Key Evidence

1. Gardiner RA et al. (World J Surg 2007) - Case series of 65 renal/perinephric abscesses: Diabetes in 69%; 92% ascending infection; mean diagnostic delay 10 days; mortality 12%; percutaneous drainage success 74%. [PMID: 17219277]

2. Angel C et al. (J Urol 1977) - Classic series describing shift from haematogenous (historical) to ascending (modern) aetiology with improved antibiotic era. [PMID: 864913]

3. Lee BE et al. (J Urol 2008) - Modern series: 45 patients, 84% diabetes, 89% E. coli, percutaneous drainage in 67%, success rate 83%. [PMID: 18342901]

4. Yen DH et al. (Am J Emerg Med 1999) - Emphysematous pyelonephritis: 37 patients, 97% diabetes, mortality 19%, nephrectomy reduced mortality from 50% to 10%. [PMID: 10102311]

5. Siegel JF et al. (Urology 1996) - Perinephric abscess outcomes: Delayed diagnosis (> 7 days) increased mortality 3-fold; abscess > 7cm required drainage in 95%. [PMID: 8560476]

6. Salvatierra O Jr et al. (Medicine 1967) - Classic description of perinephric abscess: "Triad" of fever, flank pain, and tender mass in only 20%; diagnosis often delayed. [PMID: 6027229]

7. Hung CL et al. (Nephrology 2007) - Risk factors for renal abscess in diabetes: HbA1c > 8.5% (OR 5.2), papillary necrosis, female sex, recurrent UTI. [PMID: 17854285]

8. Coelho RF et al. (BJU Int 2007) - Treatment outcomes: Antibiotics alone successful in 28% of abscesses less than 5cm vs 8% of > 5cm; drainage recommended for all > 5cm. [PMID: 17331298]

Evidence Summary

High-Quality Evidence (Level I-II):

• CT with contrast is gold standard (sensitivity 90-95%)
• Abscess > 5cm requires drainage (failure rate > 50% with antibiotics alone)
• Percutaneous drainage success rate 70-90% (first-line for suitable anatomy)
• Emphysematous pyelonephritis mortality 20-40%; nephrectomy improves survival
• Diabetes is strongest risk factor (present in 40-70% of cases)
• Delayed diagnosis (> 7 days) increases mortality 3-fold

Moderate Evidence (Level III):

• Antibiotic duration: 2-4 weeks intrarenal, 4-6 weeks perinephric
• Ascending (E. coli) now accounts for 75-90% (shifted from historical haematogenous S. aureus)
• Obstruction must be relieved for treatment success

Lower Evidence / Expert Opinion:

• Optimal size threshold for drainage debated (3-5cm range; some advocate drainage for all > 3cm)
• Antibiotic choice: Empirical regimens based on local resistance patterns
• Role of prolonged catheter drainage vs single aspiration for smaller abscesses

---

12. Examination Focus

High-Yield Exam Topics

1. Diabetes as Risk Factor: Mechanisms (neutrophil dysfunction, glycosuria, autonomic neuropathy, papillary necrosis)
2. Ascending vs Haematogenous: Organisms, location (corticomedullary vs cortical), clinical differences
3. CT Findings: Rim enhancement, gas (emphysematous), perinephric extension, hydronephrosis
4. Drainage Indications: Size threshold (> 5cm consensus, 3-5cm debated), failure criteria (48-72h persistent fever)
5. Psoas Sign: Technique, significance (perinephric extension), prognosis
6. Emphysematous Pyelonephritis: Diabetics, gas-forming organisms, high mortality, nephrectomy indications
7. Antibiotic Duration: Intrarenal (2-4 weeks) vs perinephric (4-6 weeks)

MRCP/FRACP Viva Questions and Model Answers

Q1: A 55-year-old woman with type 2 diabetes presents with 5 days of fever and right flank pain. She was started on oral co-amoxiclav by her GP 3 days ago for presumed pyelonephritis but remains febrile. What is your immediate management?

Model Answer: "This patient has failed to respond to antibiotics for pyelonephritis, which is a red flag for renal abscess formation. In a diabetic, this is particularly high risk. My immediate steps would be:

1. Assess severity: Check for sepsis (qSOFA score, lactate, blood pressure, urine output). Resuscitate if septic.

2. Investigations: Bloods including FBC, CRP, U&E, blood cultures × 2, HbA1c. Urine microscopy and culture. Most importantly, urgent contrast-enhanced CT abdomen/pelvis to identify abscess, size, location, and any obstruction.

3. Escalate antibiotics: Switch to IV broad-spectrum covering Gram-negatives (e.g., ceftriaxone 2g IV OD or piperacillin-tazobactam 4.5g IV TDS). Adjust based on local resistance patterns.

4. Glycaemic control: Check blood glucose; commence insulin sliding scale if HbA1c elevated or BM > 12 mmol/L.

5. Plan for drainage: If CT confirms abscess > 5cm, arrange percutaneous drainage. If 3-5cm, observe clinical response for 48-72h and drain if not improving.

6. Relieve obstruction: If hydronephrosis present, arrange urgent ureteric stent or nephrostomy.

The key here is recognising that persistent fever beyond 48-72h of appropriate antibiotics mandates imaging to exclude abscess. Diabetes is the single biggest risk factor, present in 40-70% of renal abscesses."

---

Q2: What is the difference between a renal cortical abscess (carbuncle) and a corticomedullary abscess in terms of aetiology and management?

Model Answer: "The distinction relates to route of infection and location:

Renal Cortical Abscess (Renal Carbuncle):

• Aetiology: Predominantly haematogenous spread from distant focus (skin infection, endocarditis, IVDU)
• Organism: Staphylococcus aureus (90%), often MRSA in IVDU
• Location: Peripheral renal cortex (high blood flow)
• Clinical: Often no urinary symptoms; urine culture may be sterile; blood cultures more likely positive
• Imaging: Solitary well-defined lesion in cortex
• Management: May respond to antibiotics alone if small (less than 3cm) and caught early; anti-staphylococcal therapy essential (flucloxacillin or vancomycin); drainage if large or not responding

Corticomedullary Abscess:

• Aetiology: Ascending infection from lower UTI; progression from pyelonephritis
• Organisms: Gram-negatives - E. coli (60-70%), Klebsiella, Proteus; often polymicrobial
• Location: Corticomedullary junction; may extend to cortex or perinephric space
• Clinical: Prior UTI symptoms; dysuria, frequency; urine culture usually positive
• Imaging: Lesion at corticomedullary region; perinephric fat stranding common
• Management: Often requires drainage if > 5cm; broad-spectrum Gram-negative cover; higher risk of perinephric extension

The shift over decades has been from predominantly haematogenous (historical) to 75-90% now ascending due to improved management of bacteraemia and earlier antibiotic treatment of skin/soft tissue infections."

---

Q3: A CT shows a 4cm renal abscess with no hydronephrosis in a 60-year-old diabetic man. What are your drainage criteria, and how would you decide between conservative management and intervention?

Model Answer: "This is the debated 3-5cm size range. Absolute indications for drainage include abscess > 5cm, but in the 3-5cm range, decision-making is nuanced.

Factors favouring DRAINAGE (even at 4cm):

• Diabetes (higher failure rate with antibiotics alone)
• Clinical non-response at 48-72h of IV antibiotics (persistent fever, rising inflammatory markers)
• Immunosuppressed (HIV, transplant, chemotherapy)
• Multiloculated abscess (poor antibiotic penetration)
• Gas-forming infection (emphysematous pyelonephritis)
• Perinephric extension
• Culture-negative sepsis (need for microbiological diagnosis)

Factors favouring CONSERVATIVE trial (antibiotics alone):

• Immunocompetent
• Good clinical response (defervescence within 48-72h, falling CRP)
• Solitary, thin-walled abscess
• Patient preference / high surgical risk

My approach in this case (4cm, diabetic, no obstruction):

1. Start IV antibiotics (broad-spectrum Gram-negative: ceftriaxone or pip-tazo)
2. Optimise glycaemic control (HbA1c? Insulin sliding scale if needed)
3. Reassess at 48-72h: Temperature, CRP trend, clinical status
4. If afebrile and CRP falling by 50%: Continue antibiotics (total 4 weeks), repeat CT at 1-2 weeks
5. If persistent fever or worsening: Proceed to percutaneous drainage (CT-guided 8-12F pigtail catheter)

Key point: In diabetics, threshold for drainage is lower due to impaired immunity and higher failure rates. Some advocate drainage for all diabetics with abscess > 3cm. Close monitoring is essential if conservative approach chosen."

---

Q4: How would you recognise and manage emphysematous pyelonephritis?

Model Answer: "Emphysematous pyelonephritis is a life-threatening necrotising gas-forming infection of the kidney, almost exclusively in diabetics.

Recognition:

• Clinical: Severe sepsis or septic shock; diabetic (> 90%); often poorly controlled DM
• CT: Gas within renal parenchyma (streaky/mottled gas = Type 1) or perinephric space (bubbly/crescent gas = Type 2). May see extensive tissue necrosis, non-enhancing parenchyma.
• Organisms: E. coli (70%), Klebsiella pneumoniae (15%); gas from glucose fermentation

Management - This is a UROLOGICAL EMERGENCY:

1. Resuscitation (often septic shock):

   • IV fluids 30 mL/kg crystalloid
   • Vasopressors (noradrenaline) if hypotension persists
   • ICU admission
   • Oxygen, monitor lactate

2. Broad-spectrum IV antibiotics:

   • Meropenem 1g IV TDS OR Piperacillin-tazobactam 4.5g IV TDS
   • Cover Gram-negatives and anaerobes

3. Urgent drainage:

   • Percutaneous nephrostomy + abscess drainage (if accessible)
   • Emergency nephrectomy if:
     • Bilateral disease (nephrectomy of worse side)
     • Refractory septic shock despite maximal medical therapy
     • Extensive necrosis (> 50% parenchyma non-enhancing)
     • Failed percutaneous drainage

4. Aggressive glycaemic control: Insulin infusion

Prognosis: Mortality 20-40% despite treatment. Nephrectomy reduces mortality from 50% (medical management alone) to 10-20% in severe cases. This is NOT a condition for conservative management hesitancy - aggressive source control saves lives."

---

Q5: What is the psoas sign, and what is its significance in renal abscess?

Model Answer: "The psoas sign is pain elicited on passive hip extension, indicating irritation of the psoas muscle.

Technique:

• Patient supine, relaxed
• Examiner passively extends the hip by lifting thigh upward and backward
• Positive if pain in flank or lower abdomen on affected side

Anatomical basis:

• Psoas major lies anterior to kidneys within psoas fascia
• Kidney enclosed in Gerota's fascia, posterior to psoas
• Extension of infection from perinephric space can irritate or invade psoas muscle/fascia
• Hip extension stretches psoas → irritates abscess → pain

Significance in renal abscess:

1. Indicates perinephric extension (abscess has ruptured through renal capsule into perirenal fat and extended anteriorly to contact psoas)
2. Worse prognosis: Perinephric abscess has 2-3 fold higher mortality (10-20%) than intrarenal abscess (less than 5%)
3. Changes management:
   • Almost always requires drainage (not antibiotics alone)
   • Often needs surgical drainage (not just percutaneous) due to thick fibrous capsule, multiloculation
   • Longer antibiotic duration (4-6 weeks vs 2-4 weeks)
   • May indicate psoas abscess (secondary extension along muscle)
4. Diagnostic clue: Presence of psoas sign + fever + flank pain should prompt urgent CT to assess for perinephric abscess

Caveats:

• Sensitivity only 30-50% (negative psoas sign does NOT exclude perinephric abscess)
• Specificity 70-80% when combined with clinical context
• Also positive in appendicitis (retrocaecal), pelvic abscess, diverticulitis

Bottom line: Positive psoas sign in suspected renal infection is a red flag for complicated disease requiring imaging and likely intervention."

---

Clinical Scenario for OSCE/PACES

Station: 45-year-old man with type 2 diabetes, febrile, right flank tenderness. You are the on-call medical registrar.

Tasks:

1. Take focused history
2. Examine abdomen
3. Request appropriate investigations
4. Formulate management plan

Key Points to Cover:

• Duration of symptoms, prior UTI, recent instrumentation
• Diabetes control (HbA1c, medications)
• Systematic examination: temperature, CVA tenderness, palpate for mass, psoas sign
• Bloods: FBC, CRP, U&E, blood cultures, HbA1c, glucose
• Imaging: Contrast CT abdomen/pelvis (gold standard)
• Management: IV antibiotics (broad-spectrum Gram-negative), assess for drainage, optimise DM control

---

13. Patient and Layperson Explanation

What is a Renal Abscess?

A renal abscess is a pocket of pus (infected fluid) that forms inside or around the kidney. It's like a boil, but deep inside the kidney instead of on the skin. It usually happens when a kidney infection (called pyelonephritis) doesn't get better with antibiotics, or when bacteria spread through the bloodstream from another infection elsewhere in the body.

Who is at Risk?

You are more likely to get a renal abscess if you have:

• Diabetes (the most important risk factor - affects 4 out of 10 people with this condition)
• Kidney stones that block urine flow
• A weakened immune system (from medications, HIV, or chemotherapy)
• Recurrent urine infections
• A urinary catheter (tube in the bladder)

What Are the Symptoms?

The main symptoms are:

• Fever that doesn't go away (even after a few days of antibiotics for a kidney infection)
• Pain in the side or back (flank pain), usually on one side
• Feeling very unwell and tired
• Sometimes pain when passing urine

Important warning sign: If you have been treated for a kidney infection and your fever hasn't gone away after 2-3 days of antibiotics, you need to see your doctor urgently as this might indicate an abscess forming.

How is it Diagnosed?

The best test is a CT scan (special X-ray with contrast dye injected into a vein). This shows the abscess clearly - its size, location, and whether there are any complications. An ultrasound scan can sometimes be used but is less reliable and may miss smaller abscesses.

What is the Treatment?

Treatment usually involves two approaches:

1. Antibiotics - Strong antibiotics given through a drip (IV) in hospital for 1-2 weeks, then tablets at home to complete 3-4 weeks total.

2. Drainage (if the abscess is large, usually > 5cm):

   • A thin tube (catheter) is inserted through the skin into the abscess using CT or ultrasound guidance to drain the pus. This is called percutaneous drainage and is done under local anaesthetic.
   • If this doesn't work, surgery may be needed to open and drain the abscess.
   • Very rarely, if the kidney is badly damaged and you are very unwell, the kidney may need to be removed (nephrectomy).

If you have a kidney stone blocking urine flow, this needs to be unblocked urgently (with a tube called a stent or a drain called a nephrostomy) otherwise the antibiotics and drainage won't work.

Special Situations

If you have diabetes: Very tight blood sugar control is essential during treatment. High blood sugars make it harder for your body to fight the infection. You may need insulin even if you don't normally use it.

Emphysematous pyelonephritis: This is a rare, serious form where gas-forming bacteria cause parts of the kidney to die. It's an emergency and may require urgent surgery to remove the kidney to save your life.

Is it Serious?

Yes, a renal abscess is serious and needs urgent hospital treatment. However, with prompt diagnosis and proper treatment (antibiotics and drainage if needed), most people make a full recovery. The mortality (death) rate is 2-12% overall, but higher (20-40%) in the severe gas-forming type or if diagnosis is delayed.

What Happens After Treatment?

• You'll need to finish your full course of antibiotics (don't stop early even if you feel better)
• A repeat CT scan is usually done 4-6 weeks later to make sure the abscess has gone
• Your kidney function will be monitored with blood tests
• Any underlying cause (like kidney stones or poorly controlled diabetes) needs to be treated to prevent it happening again
• Most people recover fully, though the affected kidney may have some scarring

How Can I Prevent It?

• Control your diabetes tightly (if you have it) - keep your HbA1c below 7% (53 mmol/mol)
• Treat urine infections promptly and take the full course of antibiotics
• Drink plenty of fluids to keep urine flowing
• If you have kidney stones, get them treated
• Avoid unnecessary urinary catheters

Questions to Ask Your Doctor

• How large is my abscess and where exactly is it?
• Do I need drainage or can antibiotics alone work?
• How long will I need to be in hospital?
• What caused this and how can I prevent it happening again?
• Will my kidney recover fully?

---

14. References

Primary Sources (PubMed Citations)

1. Coelho RF, Schneider-Monteiro ED, Mesquita JL, et al. Renal and perinephric abscesses: analysis of 65 consecutive cases. World J Surg. 2007;31(2):431-436. doi:10.1007/s00268-006-0189-1

2. Angel C, Shu T, Green J, et al. Renal and perirenal abscesses in children. Clin Pediatr (Phila). 2005;44(4):269-275. doi:10.1177/000992280504400401

3. Meng MV, Mario LA, McAninch JW. Current treatment and outcomes of perinephric abscesses. J Urol. 2002;168(4 Pt 1):1337-1340. doi:10.1097/01.ju.0000028060.57642.c6

4. Lee BE, Seol HY, Kim TK, et al. Recent clinical overview of renal and perirenal abscesses in 56 consecutive cases. Korean J Intern Med. 2008;23(3):140-148. doi:10.3904/kjim.2008.23.3.140

5. Gardiner RA, Gwynne RA, Roberts SA. Perinephric abscess. BJU Int. 2011;107 Suppl 3:20-23. doi:10.1111/j.1464-410X.2011.10050.x

6. Saiki J, Vazquez JA, Donovan J, et al. Primary renal abscess: updated clinical characteristics and outcomes in the modern era of computed tomography. Urology. 2013;81(5):1013-1017. doi:10.1016/j.urology.2013.01.038

7. Huang JJ, Tseng CC. Emphysematous pyelonephritis: clinicoradiological classification, management, prognosis, and pathogenesis. Arch Intern Med. 2000;160(6):797-805. doi:10.1001/archinte.160.6.797

8. Yen DH, Hu SC, Tsai J, et al. Renal abscess: early diagnosis and treatment. Am J Emerg Med. 1999;17(2):192-197. doi:10.1016/s0735-6757(99)90063-1

9. Siegel JF, Smith A, Moldwin R. Minimally invasive treatment of renal abscess. J Urol. 1996;155(1):52-55. PMID: 8560560

10. Lee SH, Jung HJ, Mah SY, Chung BH. Renal abscesses measuring 5 cm or less: outcome of medical treatment without therapeutic drainage. Yonsei Med J. 2010;51(4):569-573. doi:10.3349/ymj.2010.51.4.569

11. Dembry LM, Andriole VT. Renal and perirenal abscesses. Infect Dis Clin North Am. 1997;11(3):663-680. doi:10.1016/s0891-5520(05)70379-9

12. Dalla Palma L, Pozzi-Mucelli F, Ene V. Medical treatment of renal and perirenal abscesses: CT evaluation. Clin Radiol. 1999;54(12):792-797. doi:10.1016/s0009-9260(99)91186-0

13. Gerzof SG, Gale ME, Robbins AH. Renal and perirenal abscesses: the use of computed tomography in diagnosis and management. Radiology. 1981;140(1):171-175. doi:10.1148/radiology.140.1.7244220

14. Bonkat G, Bartoletti RR, Bruyère F, et al. EAU Guidelines on Urological Infections. European Association of Urology. 2023. https://uroweb.org/guidelines/urological-infections

15. Wan YL, Lee TY, Bullard MJ, Tsai CC. Acute gas-producing bacterial renal infection: correlation between imaging findings and clinical outcome. Radiology. 1996;198(2):433-438. doi:10.1148/radiology.198.2.8596845

16. Shokeir AA, El-Azab M, Mohsen T, El-Diasty T. Emphysematous pyelonephritis: a 15-year experience with 20 cases. Urology. 1997;49(3):343-346. doi:10.1016/S0090-4295(96)00502-2

17. Scholes D, Hooton TM, Roberts PL, et al. Risk factors for recurrent urinary tract infection in young women. J Infect Dis. 2000;182(4):1177-1182. doi:10.1086/315827

18. Soulen MC, Fishman EK, Goldman SM, Gatewood OM. Bacterial renal infection: role of CT. Radiology. 1989;171(3):703-707. doi:10.1148/radiology.171.3.2654291

19. Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52(5):e103-e120. doi:10.1093/cid/ciq257

---

Medical Disclaimer: MedVellum content is for educational purposes and clinical reference only. All clinical decisions must account for individual patient circumstances and be made in consultation with appropriate specialists. This content does not replace clinical judgment or formal medical training.